THE PSA is calling on all Govts to allow pharmacists to administer the recently approved first respiratory syncytial virus (RSV) vaccine, as it would "significantly improve its uptake" and reduce hospitalisations from severe infections.
"Having a vaccine on the market is not enough, we need to ensure that it's as accessible as possible to those who need it most," said PSA President Fei Sim (pictured).
"Pharmacist immunisers are limited by red tape and regulation imposed by states and territories, preventing them from fulfilling their potential to administer all vaccines to all at-risk Australians."
Millions of Australians attend pharmacies for their vaccinations, with more than 15 million COVID-19 and influenza vaccines administered by pharmacists over the last few years, PSA stated.
"By making vaccinations more accessible to vulnerable groups, we can limit the serious health complications RSV can cause and in turn reduce hospitalisations."
Sim added that allowing pharmacists to practice to the top of their scope makes efficient use of health resources, benefitting the broader health system.
"I urge all state and territory govts to authorise pharmacists to provide the RSV vaccine, supporting access to preventive care and keeping older Australians healthy and well," she urged.
"This access should extend to all vaccines, for all eligible people, in all locations in Australia where pharmacists work.
"Reducing barriers to vaccination, reducing barriers to care, should always be our priority," Sim said. JG
The above article was sent to subscribers in Pharmacy Daily's issue from 22 Jan 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Jan 24
